World of DTC Marketing

FEBRUARY 28, 2021

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. So should we forget all that because they developed a COVID vaccine?

Vaccination 180

Vaccination Vaccine Contamination Compliance 180

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 78

Pharma Companies Drugs Medicine Development 78

pharmaphorum

NOVEMBER 3, 2021

The development of digital medicine requires valid endpoints that can be used in clinical trials, and a consortium of pharma companies has just identified a new one for atopic dermatitis. The post Pharma group will develop ‘digital endpoint’ for atopic dermatitis appeared first on.

Development 72

Development Pharma Companies Trials Clinical Trials 72

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

BioPharma Reporter

FEBRUARY 18, 2021

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Pharma Companies 52

Pharma Companies Development Manufacturing Drugs 52

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals. Headway being made.

Development 98

Development Genome Genomics Drugs 98

World of DTC Marketing

DECEMBER 14, 2021

According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. In contrast, insulin prices in other developed countries, including neighboring Canada, have stayed the same. It’s time to admit that pharma is out of control.

Insulin 184

Insulin Branding Drugs Production 184

Pharma Marketing Network

APRIL 10, 2025

Table of Contents Why PPC Campaigns Work for Pharma Strategic Audience Targeting and Keyword Planning Compliance, Creativity, and Conversion Optimization Measuring Success: Metrics That Matter Why PPC Campaigns Work for Pharma PPC campaigns deliver ads to users actively searching for health-related topics, treatments, or branded medications.

Marketing 52

Marketing Branding Compliance Pharma Companies 52

Outsourcing Pharma

DECEMBER 12, 2023

Clinical-stage pharma company, PharmaKure which develops precision medicine for Alzheimerâs Disease and other neurological diseases has announced a collaboration agreement with one of the largest comprehensive universities in Malaysia.

Pharma Companies 93

Pharma Companies Medicine Development Regulation 93

pharmaphorum

SEPTEMBER 30, 2021

The new guidance is the first of a series that have been promised by the US regulator to develop a framework for regulating RWD, which is increasingly being used by pharma companies to investigate how their medicines perform beyond the controlled environment of clinical trials.

Pharma Companies 95

Pharma Companies Regulation Clinical Trials Clinical Trials 95

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 109

Marketing Regulation Production Medicine 109

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Clinical Trials 246

Clinical Trials Clinical Trials Gene Therapy Clinical Supply Chain 246

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 52

Pharma Companies Drugs Medicine Development 52

pharmaphorum

AUGUST 4, 2020

The company’s shares were valued as high as 95p on the London Stock Exchange following the announcement, the highest they had been since 2015. AstraZeneca has bought an exclusive global licence to develop and market RXC006, a porcupine inhibitor for fibrotic diseases including idiopathic pulmonary fibrosis (IPF).

Drugs 109

Drugs Clinical Trials Clinical Trials Pharma Companies 109

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. Will we go back to that?

Marketing 100

Marketing Doctor Doctors Pharma Companies 100

World of DTC Marketing

JUNE 24, 2021

Safety pages on Pharma product websites continue to have high utility. As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. Only requirement in TV ads should be for “boxed” products.

Doctor 165

Doctor Doctors Production Drugs 165

pharmaphorum

DECEMBER 8, 2020

AbCellera is a specialist in applying artificial intelligence to drug discovery, specifically to sift through immune system data to find antibodies that can be developed as drugs. Its approach involves licensing rights to the antibodies to other pharma companies, rather than bringing its own candidates through development.

Drugs 111

Drugs Antibody FDA Approval Pharma Companies 111

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

pharmaphorum

FEBRUARY 1, 2021

Biogen filed aducanumab with the FDA in July last year and the regulator granted a faster six-month Priority Review in August lasty year. Development of aducanumab has been far from straight forward. With the extension the FDA is now due to make a decision on aducanumab by 7 June.

Pharma Companies 96

Pharma Companies Drugs Regulation Development 96

pharmaphorum

SEPTEMBER 29, 2020

The regulator also specified that the ECG and irregular rhythm notification functions are not intended to be used by people under the age of 22, a group which made up around 9% of the 264-subject sample, or those previously diagnosed with AFib.

Pharma Companies 122

Pharma Companies Doctors Doctor Regulation 122

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. We have also seen the regulators actively support the use of these hybrid decentralised research approaches. New sensor technology revolutionising data collection. Novel digital endpoints.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

pharmaphorum

DECEMBER 22, 2021

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. CFI regulates the activity of the complement immune system which is over-activated in GA. It has been fast-tracked by the FDA.

Gene Therapy 105

Gene Therapy Gene Licensing Licensing 105

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. It’s much needed. It’s a hot area.”

Drugs 130

Drugs Gene Therapy Regulation Insulin 130

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

pharmaphorum

JUNE 16, 2022

There are already more than 30 DiGAs that have approved for use by the BfArM medical regulator and are covered by the national GKV health insurance system. Germany recorded almost 70,000 new cases of breast cancer in 2020, according to World Health Organization (WHO) figures, accounting for 11% of all forms of cancer.

Hormones 103

Hormones Pharma Companies Regulation Drugs 103

BioPharma Reporter

SEPTEMBER 19, 2023

The big pharma company Bristol Myers Squibb (BMS) has recruited contract manufacturing and development organization (CDMO) Samsung Biologics to manufacture a commercial antibody cancer treatment until 2030.

Manufacturing 59

Manufacturing Contract Manufacturing Pharma Companies Antibody 59

pharmaphorum

JANUARY 24, 2022

“The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharma companies.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

Pharma Marketing Network

DECEMBER 31, 2024

Ensure Regulatory Compliance Navigating regulations can feel daunting, but its crucial. Develop blogs, white papers, and videos that educate and engage. Why is digital marketing crucial for pharma companies? How can pharma marketers stay compliant with regulations?

Marketing 52

Marketing Branding Compliance Drugs 52

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Marketing 105

Marketing Drugs Development Regulation 105

pharmaphorum

JANUARY 3, 2023

Data governance and compliance are critical for ensuring that sensitive data is handled and stored securely and in accordance with relevant laws and regulations. This can facilitate collaboration and innovation, and drive the development of new and exciting applications and services. Automated compliance. Data monetisation. Challenges.

Compliance 105

Compliance Regulation Pharma Companies Genetics 105

Pharma Marketing Network

OCTOBER 12, 2023

Benefits of VR & AR in Pharma Advertising VR and AR offer a unique opportunity for pharma companies to engage with customers in a more immersive and interactive way. For example, by using VR and AR, a pharma company could create an interactive 3D environment that allows customers to explore the product in detail.

Pharma Companies 52

Pharma Companies Production Compliance Development 52

Pharmaceutical Technology

DECEMBER 22, 2022

However, now that the implementation of Regulation (EU) 2021/2282 on health technology assessment (HTA) is a reality, a constructive discussion between the industry and regulators is needed.

Medicine 130

Medicine Regulation Marketing Production 130

pharmaphorum

NOVEMBER 3, 2022

We see how digital measures of adherence ensure that sample size calculations hold and drug developers can accurately evaluate the safety and efficacy of new molecules. Pharma companies with more mature digital strategies are able to focus on questions of scale. Moving towards implementation. To us, the benefits are clear.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Medicine 81

pharmaphorum

FEBRUARY 24, 2021

The FDA has issued guidelines allowing for faster development of updated coronavirus vaccines, based on previously approved shots that have been tweaked to combat emerging variants of the SARS-CoV-2 virus. If regulators are okay with immunogenicity studies we aim to start vaccinating (with updated version) in the autumn,” he added.

Vaccination 59

Vaccination Vaccine Immune Response Regulation 59

pharmaphorum

MARCH 12, 2021

As moderator Gareth Powell – business development officer, patient engagement and clinical development service project lead at the NIHR – noted, the Institute has seen fantastic feedback from patients on the increased use of virtual engagement over the course of pandemic. Our young persons’ advisory groups are busier than ever.”.

Trials 132

Trials Research Pharma Companies Clinical Trials 132

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. The pharma company will use the technology known as accelerateIQ to collect data across its clinical studies through a variety of wearable biosensors.

Licensing 72

Licensing Licensing Trials Clinical Trials 72